Detalles de la búsqueda
1.
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?
J Sleep Res
; 31(1): e13400, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34137095
2.
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
CNS Spectr
; 27(3): 322-330, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267928
3.
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
CNS Spectr
; 27(3): 315-321, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298225
4.
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
Am J Geriatr Psychiatry
; 29(9): 899-913, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478865
5.
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
Bipolar Disord
; 22(8): 831-840, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32406161
6.
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
Med
; 5(3): 190-200.e5, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359838
7.
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
J Psychopharmacol
; 37(8): 775-783, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194253
8.
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.
Psychiatry Res
; 323: 115133, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889160
9.
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study.
JMIR Ment Health
; 9(10): e33871, 2022 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36301615
10.
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment.
J Affect Disord
; 288: 210-216, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965843
11.
The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence.
Psychiatry Res
; 300: 113860, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836470
12.
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence.
J Psychiatr Res
; 143: 209-214, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507101
13.
Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence.
J Psychiatr Res
; 136: 444-451, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32948309
14.
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.
J Affect Disord
; 282: 160-164, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418362
15.
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
J Psychopharmacol
; 35(2): 128-136, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040665
16.
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic.
Psychiatry Res
; 303: 114086, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246008
17.
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?
J Affect Disord
; 292: 714-719, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161889
18.
The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE).
Psychiatry Res
; 302: 113993, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034067
19.
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
J Affect Disord
; 294: 592-596, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332360
20.
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
Prog Neuropsychopharmacol Biol Psychiatry
; 105: 110126, 2021 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33031861